First Tracks Biotherapeutics Inc enterprise value

The Enterprise Value as of October 2026 (TTM) for First Tracks Biotherapeutics Inc (TRAX) is 1.38B

According to First Tracks Biotherapeutics Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.38B. This represents a change of 648.72% compared to the average of 184.01M of the last 4 quarters.

First Tracks Biotherapeutics Inc (TRAX) Historical Enterprise Value (quarterly & annually)

How has TRAX Enterprise Value performed in the past?

The mean historical Enterprise Value of First Tracks Biotherapeutics Inc over the last ten years is 543.80M. The current 1.38B Enterprise Value has changed 153.35% with respect to the historical average. Over the past ten years (40 quarters), TRAX's Enterprise Value was at its highest in in the June 2026 quarter at 548.38M. The Enterprise Value was at its lowest in in the December 2025 quarter at -224084000.00.

First Tracks Biotherapeutics Inc (TRAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of First Tracks Biotherapeutics Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

First Tracks Biotherapeutics Inc (TRAX) Average Enterprise Value

How has TRAX Enterprise Value performed in the past?

The current Enterprise Value of First Tracks Biotherapeutics Inc (TRAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

First Tracks Biotherapeutics Inc (TRAX) Enterprise Value vs. Peers

How is TRAX’s Enterprise Value compared to its peers?

First Tracks Biotherapeutics Inc’s Enterprise Value is less than AnaptysBio, Inc. (1.57B), greater than Attovia Therapeutics, Inc. (633.44M), greater than SAB Biotherapeutics, Inc. (273.46M), greater than MoonLake Immunotherapeutics (673.84M), greater than Aclaris Therapeutics, Inc. (544.60M), greater than Odyssey Therapeutics, Inc. (859.75M), less than Immunovant, Inc. (5.21B), greater than Immunic, Inc. (-56017955.00), greater than Eledon Pharmaceuticals, Inc. (180.56M), greater than Climb Bio, Inc. (562.59M),

Build a custom stock screener for First Tracks Biotherapeutics Inc (TRAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like First Tracks Biotherapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

First Tracks Biotherapeutics Inc (TRAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like First Tracks Biotherapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.